Blog

Technology

 August 13, 2018

In the News: August 9–16

By

This week: Hospitals’ investment in artificial intelligence is expected to increase; a study finds opioid prescribing decreases after physicians learn of a patient’s fatal overdose; and CMS proposes restructuring ACO...

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 April 16, 2018

In the News: April 12–19

By

This week: CMS final rule lets states define essential health benefits; health system expansion may result in patient safety risks; and the FDA approves the first autonomous AI medical device

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 February 17, 2018

“Digiceuticals” Are Gaining Steam

By

“Digiceuticals” Are Gaining Steam For several months now, the FDA has been approving mHealth apps (also known as digital therapeutics or “digiceuticals”) to treat everything from diabetes to substance abuse....

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 December 18, 2017

In the News: December 14–21

By

This week: Tax reform bill passes House and Senate, gene therapy for hemophilia, a nationally backed continuum of care for mental health and the repeal of net neutrality

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 October 6, 2017

Precision Medicine: Hits and Misses

By

Precision medicine is so broad, you need to focus your investment. This post describes the 3 main activities—screening, diagnostics and therapeutics—associated with precision medicine and outlines which service lines are being...

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube